Investor Presentaiton

III Key Investment Highlights 2 Attractive Industry Dynamics (II/II) A highly defensive sector with significant room for continued growth Pharma Market Share Public Sector 3% Novartis 8% Market Segmentation | Market Share FY2017 Multinational 48% FY 2017 Manu. Others 56% GENERIC Private Sector 49% GSK 6% Sanofi 5% Pharco 5% ISP 19.2% Dist.1 Retail Amoun 5% Others 31.8% UCP 32.9% Other 92% Eipico 4% Eva 4% Pfizer 3% Hikma 2% Global Napi 2% POS 16.1% The distribution space is the most consolidated segment, with the 3 largest players processing 68% of the market sales Growth Drivers Higher Priced Drug Pricing Adjustment Increasing Generic Replacements Waves Uptake ibnsinapharma (1): Data for full year 2017 Source: IMS Health, BMI, WHO IN Ezaby 4% Seif 2% Roushdy 2% Misr 1% Increase of Chronic Diseases Ageing & Growing Population New Products - New Markets Strictly Private & Confidential 13

View entire presentation